Obesity reviews : an official journal of the International Association for the Study of Obesity

Effectiveness and safety of medicines for managing heart and metabolism risks in overweight and obese young people

Updated

Abstract

Pooled analysis on 30 randomized clinical trials showed that high dose phentermine/topiramate resulted in a 15.8 kg reduction in weight compared to placebo.

  • High dose phentermine/topiramate was associated with a reduction in body mass index (BMI) by 5.35 kg/m² and waist circumference by 7.69 cm compared to placebo.
  • Liraglutide and metformin were linked to significant reductions in fasting blood glucose levels, with liraglutide showing a decrease of 11.00 mg/dL.
  • Orlistat demonstrated a decrease in diastolic blood pressure by 1.81 mmHg compared to placebo.
  • No significant changes were observed in lipid profiles or systolic blood pressure from any of the studied drugs.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free